• Adult Immunization
  • Hepatology
  • Pediatric Immunization
  • Screening
  • Psychiatry
  • Allergy
  • Women's Health
  • Cardiology
  • Pediatrics
  • Dermatology
  • Endocrinology
  • Pain Management
  • Gastroenterology
  • Geriatrics
  • Infectious Disease
  • Obesity Medicine
  • Rheumatology
  • Oncology
  • Nephrology
  • Neurology
  • Pulmonology

After Metformin: Which Class Would you Choose?

News
Slideshow

In this older patient with T2DM, HFpEF, and other comorbidities, which class of medication is most appropriate--and guideline-recommended?

Related Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Related Content
Cost of Semaglutide, Tirzepatide Prohibitive Despite Significant Benefits

Cost of Semaglutide, Tirzepatide Prohibitive Despite Significant Benefits

Grace Halsey
March 14th 2025
Article

A new economic evaluation estimates that semaglutide would need to drop its current price by 81.9% and tirzepatide by 30.5% to be cost effective.

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

Sydney Jennings
August 30th 2023
Podcast

Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.

Cardiovascular Health Maintained Over Time Linked to Reduced Risk of Neurodegenerative Disease, Study Suggests / image credit American Heart Association

Cardiovascular Health Maintained Over Time Linked to Reduced Risk of Neurodegenerative Disease, Study Suggests

Grace Halsey
March 13th 2025
Article

Higher levels of cardiovascular health were associated with lower levels of neurofilament light chain across age, sex, race/ethnicity, and Alzheimer disease risk.

Obesity & Type 2 Diabetes: An Expert Discussion

Obesity & Type 2 Diabetes: An Expert Discussion

Sydney Jennings
June 30th 2023
Podcast

In our latest episode, 2 obesity experts discuss the importance of early intervention to reduce risk for complications, suggestions for managing patients in primary care, and more.

FDA Approves First Rapid-Acting Insulin Biosimilar for Diabetes: Daily Dose / image credit: ©New Africa/AdobeStock

FDA Approves First Rapid-Acting Insulin Biosimilar for Diabetes: Daily Dose

Sydney Jennings
March 3rd 2025
Article

Your daily dose of the clinical news you may have missed.

FDA Clears Google Pixel Watch 3 Loss of Pulse Detection Feature

FDA Clears Google Pixel Watch 3 Loss of Pulse Detection Feature

Sydney Jennings
February 28th 2025
Article

The Loss of Pulse Detection feature will begin rolling out in the US late next month.

© 2025 MJH Life Sciences

All rights reserved.